Arch Therapeutics Inc (ARTH)

[Polyphemus]

OK, got the point. ARCH financial statements might be technically accurate in a limited sense, but leave out important information. However, I don't see on this board any concern about company fundamentals. Is this situation typical of this class of stocks, or it due to the fact that the finanical situation of ARTH is so tenuous that fundamental questions don't get asked or commented up? Is it so late in the day that this becomes a game (gambling) of musical chairs? Opinions?